Chungnam National University Hospital
Daejeon, Munhwa-ro 282, Jung-gu, South Korea
NCT Number: NCT03317106
this study examines the incidence of newly developed delirium in patients who admit to university hospital stroke unit for cerebral infarction, and analyze the association between delirium motor subtypes and short-term outcome in post-stroke delirium patients.
Looking for future studies?
Notify MeAll sexes
Observational
Daejeon, Munhwa-ro 282, Jung-gu, South Korea
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 weeks
mean score of delirium severity rating scale during follow up period. Detailed information about scale: Korean Version of the Delirium Rating Scale-Revised-98(K-DRS-R98) DRS-R98 proved to be a valid and reliable instrument for the assessment of delirium severity and distinguish patients with delirium from non-delirious patients including dementia. The scale is composed of two sections. The first section is the severity scale, which consists of 13 items that are scored from 0 to 3 according to a Likert scale that is anchored by descriptions of phe-nomenology. The second section consists of three diagnostic items that are scored from 0 to 2 or 3. These items include temporal onset of symptoms, fluctuation of symptom severity and physical disorder. The total scale is comprised of 16 items. The total score is the sum of the scores for each item and the higher the score, the greater the severity.
Chungnam National University Hospital
Other
the Prospective Study on the Incidence and the Association Between Motor Subtypes and Outcome of Delirium in Ischemic Stroke Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02548975
Confusion, Delirium
View Trial DetailsNCT06963112
Anxiety, Anxiety Disorders
Guangxi, China
View Trial DetailsNCT07151716
Confusion, Delirium
Beijing, Beijing Municipality, China
View Trial DetailsNCT03317067
Aberrant Motor Behavior in Dementia, Agitation
Clermont-Ferrand, France
View Trial Details